Just before the 23andMe SPAC deal closed, the stock belonging to its merger partner ... giving investors the impression it is ...

The 23andMe collapse reveals deep flaws in how companies treat personal data—not as a sacred trust, but as a disposable asset ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.

Genetic testing company 23andMe (ME) has won court approval to sell its most valuable asset, customer DNA data, despite ...

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

Opinion: LK Law Firm's Lena Kempe explores how the 23andMe bankruptcy highlights the need for stronger data protection ...

Me promised to tell you where you came from. Now, it’s not clear where your genetic data is going. With a Chapter 11 filing, ...

Just before the 23andMe SPAC deal closed, the stock belonging to ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets ...

23andMe bankruptcy underscores the risk of investing in most SPACs ... whose mission is to make acquisitions. Then the SPAC converts its ticker symbol and name over to one matching the name ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...